INTERNATIONAL PATENT: SUZHOU TRANSCENTA THERAPEUTICS CO., LTD. FILES APPLICATION FOR "COMBINATION THERAPY OF GREM1 ANTAGONIST AND ACTIVIN RECEPTOR ANTAGONIST FOR TREATING PAH"

GENEVA, July 18 -- SUZHOU TRANSCENTA THERAPEUTICS CO., LTD. (B6-501, Biobay 218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123) filed a patent application (PCT/CN2025/071165) for "COMBINATION THERAPY OF GREM1 ANTAGONIST AND ACTIVIN RECEPTOR ANTAGONIST FOR TREATING PAH" on Jan 08, 2025. With publication no. WO/2025/148900, the details related to the patent application was published on Jul 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): QIAN, Xueming (B6-501, Biobay 218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), SUN, Di (B6-501, Biobay 218 Xinghu Street, Suz...